Has Tarek Aly received payments from drug or device companies?

Yes. Drug and device makers reported $83,081 in general payments to Tarek Aly across 278 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Tarek Aly did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Tarek Aly come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Tarek Aly

Psychiatry · Daytona Beach, FLNPI 1225419559

Payments from drug & device makers

$83,081in general payments, 2019–2025

Across 278 payments — averaging $298.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$66K
Neos Therapeutics, LP$12K
Aytu Biopharma, Inc.$4K
Corium, LLC$389
Alkermes, Inc.$317
Otsuka America Pharmaceutical, Inc.$205
plus $1K from 16 others

What the payments were for

Speaking & faculty fees$73,72589%
Travel & lodging$4,4485%
Food & beverage$4,8936%
Education$150%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	116	$65,791
Neos Therapeutics, LP	45	$11,510
Aytu Biopharma, Inc.	6	$3,703
Corium, LLC	26	$389
Alkermes, Inc.	12	$317
Otsuka America Pharmaceutical, Inc.	10	$205
Lundbeck LLC	10	$204
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	11	$196
Supernus Pharmaceuticals, Inc.	8	$148
Tris Pharma Inc	8	$142
Johnson & Johnson	6	$113
Ironshore Pharmaceuticals Inc.	5	$88
Almatica Pharma LLC	3	$61
Bausch Health US, LLC	2	$38
Noven Therapeutics, LLC	2	$37
Neurocrine Biosciences, Inc.	2	$33
E.r. Squibb & Sons, L.L.C.	1	$22
Biogen	1	$19
Bioxcel Therapeutics, Inc.	1	$17
Collegium Pharmaceutical, Inc.	1	$17
Vanda Pharmaceuticals Inc.	1	$16
Takeda Pharmaceuticals U.S.A., Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$83,081 in reported general payments places this provider in the 90th percentile of 2,059 psychiatry providers in Florida.

See all psychiatry providers in Florida →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
SpravatoEsketamine Hcl	21	$25,901
Lamotrigine ErLamotrigine	28	$2,471
Vilazodone Hcl	19	$1,386
Guanfacine Hcl ErGuanfacine Hcl	47	$1,168
Duloxetine Hcl	53	$1,056
Trazodone Hcl	50	$726
Escitalopram Oxalate	50	$681
Bupropion XlBupropion Hcl	35	$581
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine	19	$502
Clonazepam	54	$480
Olanzapine	19	$442
Aripiprazole	13	$371
Quetiapine Fumarate ErQuetiapine Fumarate	15	$340
Desvenlafaxine Succinate ErDesvenlafaxine Succinate	15	$249
Diazepam	24	$203

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Johnson & JohnsonSpravato	$113	$25,90121 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,059 psychiatry providers in Florida.

Other psychiatry in Daytona Beach

Edwin GomezWeston$24.9M
Rishi KakarTamarac$23.9M
Peter VentreOakland Park$18.7M
Jose GamezHialeah$14.8M
John JoyceJacksonville$13.6M
Silvia Silva-DulucMiami$11.7M
Kelley WilsonTampa$11.1M
Emilio Mantero-AtienzaMiami Beach$10.9M
Patricia JunqueraMiami$10.8M
Olga LapeyraLauderhill$10M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →